Related Experiment Videos
Effects of heat treatment on selected plasma therapeutic drug concentrations
R A Delaney1, S L Mikkelsen, M B Jackson
1Clinical Research Laboratory, Keesler Technical Training Center Medical Center, Keesler Air Force Base, MS 39534.
Objective:
We investigated the heat stability of six common therapeutic drugs routinely assayed in pharmacokinetic and clinical laboratories.
Design:
Serum samples were spiked at three concentrations (subtherapeutic, therapeutic, and potentially toxic) with amikacin, gentamicin, tobramycin, phenytoin, theophylline, and phenobarbital. The samples were then heated at 56 degrees C and assayed by fluorescence polarization immunoassay at 15-minute intervals for one hour.
Setting:
The study was conducted at a clinical research laboratory using standard laboratory methods.
Main Outcome Measures:
Drug concentrations of heated samples were compared with unheated controls using ANOVA to determine if degradation occurred over time with heating.
Results:
Analysis of data revealed no degradation of any of the samples.
Conclusions:
Heat treatment of samples from high-risk individuals may be a mechanism to protect healthcare workers from exposure to the human immunodeficiency virus.